ADIL

Adial Pharmaceuticals Inc

• Benzinga·21h ago

  Adial Pharmaceuticals Form 13G Shows Coastlands Capital Partners Discloses 9.98% Passive Stake In Co. As Of June 17

• Reuters·22h ago

  COASTLANDS CAPITAL LP REPORTS 9.98% PASSIVE STAKE IN ADIAL PHARMACEUTICALS AS OF JUNE 17 - SEC FILING

• PUBT·06/16 12:04

  Adial Pharmaceuticals grants inducement equity awards to new chief development officer, strategy EVP

• PUBT·06/16 12:03

  Adial Pharmaceuticals appoints Matthew Davidson chief development officer, Julie Saiki EVP strategy

• Reuters·06/16 12:00

  ADIAL PHARMACEUTICALS EXPANDS EXECUTIVE LEADERSHIP TEAM AND CLOSES PIPE FINANCING

• Dow Jones·06/16 12:00

  Press Release: Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

• PUBT·06/16 10:11

  Adial Pharmaceuticals director Wendy B. Young files initial beneficial ownership statement

• Dow Jones·06/15 17:26

  Adial Pharmaceuticals Price Target Announced at $6.00/Share by LUCID CAPITAL MARKETS

• Benzinga·06/15 17:18

  LUCID CAPITAL MARKETS Initiates Coverage On Adial Pharmaceuticals with Buy Rating, Announces Price Target of $6

• TipRanks·06/15 10:11

  Adial Pharmaceuticals initiated with a Buy at Lucid Capital

• Benzinga·06/12 21:05

  12 Health Care Stocks Moving In Friday's After-Market Session

• Benzinga·06/12 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• NASDAQ·06/12 09:34

  Adial Acquires Azora With $64 Mln Private Placement; To Advance AT177 For Ulcerative Colitis

• NASDAQ·06/12 03:54

  Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...

• Benzinga·06/11 21:05

  12 Health Care Stocks Moving In Thursday's After-Market Session